SpliceBio raised $135m in Series B co-led by EQT and Sanofi, w/ Roche Venture Fund, NEA, UCB Ventures, Ysios Capital, Gilde Healthcare, Novartis and Asabys.

Biotech Health services

Investments

01 June 2025

Splice Bio (company)

Biotech Health services

Total investments received (USD): 191.88m

Round value (USD): 135m

Round investors: Asabys Partners EQT Partners Gilde Healthcare New Enterprise Associates Novartis Venture Fund Roche Venture Fund Sanofi Ventures Ysios Capital UCB Ventures

Company: Splice Bio

Industry: Biotech Health services

Related deals

Sidera Bio secures DKK 700 million in a Series A biotech round with Novo Holdings, Forbion, RA Capital Healthcare Fund LP, and Gilde Healthcare.

Biotech Health services

Investments 19 November 2025

AAVantgarde Bio to raise $141M series B co-led by Schroders Capital with existing investors Atlas Venture and Forbion

Biotech Health services

Investments 19 October 2025

Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest

Biotech Health services

Investments 16 October 2025

ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion

Biotech Health services Pharma

MA 12 October 2025

Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital,

Biotech Health services

Investments 03 October 2025

Menu

SpliceBio raised $135m in Series B co-led by EQT and Sanofi, w/ Roche Venture Fund, NEA, UCB Ventures, Ysios Capital, Gilde Healthcare, Novartis and Asabys.

Share:

Splice Bio (company)

Related deals

Sidera Bio secures DKK 700 million in a Series A biotech round with Novo Holdings, Forbion, RA Capital Healthcare Fund LP, and Gilde Healthcare.

AAVantgarde Bio to raise $141M series B co-led by Schroders Capital with existing investors Atlas Venture and Forbion

Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest

ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion

Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital,

Sidebar

Verticals

Benelux

DACH

Nordics and Baltics

Western Europe